CVS Health Corp EVP and Group President Prem S. Shah filed a Form 4 on November 6, 2026, disclosing an open-market purchase of 23,855 shares of CVS Health common stock on that same date.

Key Highlights

  • Reporting person: Prem S. Shah, EVP and Group President of CVS Health Corp (NYSE:CVS)
  • Transaction: Purchase (transaction code P) of 23,855 shares of common stock on November 6, 2026
  • Price paid: $83.895 per share, according to the filing
  • Resulting ownership: 88,516.1575 shares of common stock held directly following the transaction
  • No derivative securities were reported as acquired, disposed of, or beneficially owned in Table II

Shah's Direct Purchase of CVS Health Common Stock: November 2026

According to the filing, Prem S. Shah, identified as EVP and Group President of CVS Health Corp, reported a purchase of 23,855 shares of CVS Health common stock on November 6, 2026. The transaction was recorded under transaction code P, indicating an open-market purchase. The price listed in the filing is $83.895 per share. The filing was submitted on November 6, 2026, the same date as the transaction.

Following the reported transaction, the filing states that Shah directly beneficially owns 88,516.1575 shares of CVS Health common stock. No indirect ownership or derivative securities positions were disclosed in this filing. Table II, covering derivative securities such as options or warrants, contained no reported transactions or holdings.

Shah signed the filing on November 6, 2026. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires officers and directors to report changes in their beneficial ownership of company securities. No amendment to a prior filing was indicated.

What Was Disclosed

The Form 4 filed by Prem S. Shah, EVP and Group President of CVS Health Corp (NYSE:CVS), disclosed a purchase of 23,855 shares of common stock at $83.895 per share on November 6, 2026, bringing his direct beneficial ownership to 88,516.1575 shares.